Ken Griffin’s Stereotaxis STXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-29,700
Closed -$68.3K 14186
2025
Q4
$68.3K Buy
29,700
+9,500
+47% +$25.3K ﹤0.01% 11882
2025
Q3
$62.8K Buy
+20,200
New +$52.3K ﹤0.01% 12083
2025
Q2
Sell
-1,300
Closed -$2.29K 14989
2025
Q1
$2.29K Sell
1,300
-2,800
-68% -$5.96K ﹤0.01% 14048
2024
Q4
$9.35K Buy
4,100
+2,100
+105% +$4.39K ﹤0.01% 13652
2024
Q3
$4.08K Sell
2,000
-600
-23% -$1.21K ﹤0.01% 13597
2024
Q2
$4.73K Sell
2,600
-1,300
-33% -$2.92K ﹤0.01% 13461
2024
Q1
$10.2K Buy
3,900
+1,100
+39% +$2.61K ﹤0.01% 13468
2023
Q4
$4.9K Buy
2,800
+700
+33% +$1.13K ﹤0.01% 13471
2023
Q3
$3.32K Buy
2,100
+1,000
+91% +$1.6K ﹤0.01% 13602
2023
Q2
$1.68K Sell
1,100
-4,200
-79% -$7.79K ﹤0.01% 13887
2023
Q1
$10.8K Buy
5,300
+4,100
+342% +$9.22K ﹤0.01% 13504
2022
Q4
$2.48K Buy
+1,200
New +$2.35K ﹤0.01% 14330
2022
Q1
Sell
-12,100
Closed -$75K 14539
2021
Q4
$75K Sell
12,100
-6,300
-34% -$37.6K ﹤0.01% 12989
2021
Q3
$99K Buy
18,400
+3,100
+20% +$23.4K ﹤0.01% 12886
2021
Q2
$147K Sell
15,300
-3,200
-17% -$25.3K ﹤0.01% 12528
2021
Q1
$124K Buy
+18,500
New +$110K ﹤0.01% 12261

Other funds holding STXS

Ken Griffin's STXS Position: Q4 2025 in Review

Ken Griffin sold out of Stereotaxis (STXS) in Q4 2025, closing a stake of 102,429 shares — an estimated $273K sold.

Ken Griffin first reported a position in STXS in Q3 2013 and held it in 23 quarters. The position peaked at $1.22M in Q3 2021. 105 funds tracked by Wall St. Rank hold STXS as of Q4 2025.

  • Ken Griffin reported no remaining Stereotaxis position as of Q4 2025 after selling out during the quarter.
  • Ken Griffin sold 102,429 Stereotaxis shares in Q4 2025, an estimated $273K.
  • Ken Griffin first reported a position in Stereotaxis in Q3 2013 and held it in 23 quarters.
  • Ken Griffin's Stereotaxis position peaked at $1.22M in Q3 2021.
  • 105 funds tracked by Wall St. Rank held Stereotaxis as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.